Advancements In Cardiac Marker Testing Industry Trends Gaining Momentum in the Global Cardiac Marker Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cardiac Marker Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of cardiac marker testing has expanded at a swift pace in the last few years. The market is forecasted to grow from $6.52 billion in 2024 to $7.19 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. The previous growth data can be linked to factors such as the increase in the elderly population, the rollout of educational initiatives, enhancement in awareness, improvement in healthcare facilities, and an increase in the number of patients.

Cardiac Marker Testing Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, a significant expansion is expected in the cardiac marker testing market, with predicted growth to $10.56 billion in 2029, representing a compound annual growth rate (CAGR) of 10.1%. A surge in cardiovascular disease incidents, an increase in strategic alliances and partnerships, expanded research and development efforts, favorable reimbursement policies, and an escalated demand for point-of-care (POC) testing are the driving factors for this growth during the forecast period. Noteworthy shifts expected in the forecast period encompass enhanced diagnostic technologies, automated analyzers, improved cardiac marker testing assays, digital health technology advancements, and the advent of integrated technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report

What Are the Drivers Transforming the Cardiac Marker Testing Market?
The upward trend in cardiovascular diseases is believed to spur the expansion of the cardiac marker testing market in the future. These diseases, also known as cardiovascular diseases (CVDs), are a range of disorders impacting the heart and vascular system, encompassing ailments like coronary artery disease, heart failure, and stroke. This surge in cardiovascular diseases can be attributed to unhealthy dietary habits, lack of physical activity, tobacco usage, excessive alcohol consumption, and air pollution. For an accurate diagnosis, severity assessment, and progress or treatment-response tracking for heart-related conditions, cardiac marker testing is needed. It helps detect distinctive biomarkers that appear during myocardial damage. For example, as per the American Heart Association, a nonprofit organization based in the U.S, the standardized mortality rate due to cardiovascular disease climbed to 233.3 per 100,000 in January 2024, a 4.0% rise from 224.4 per 100,000 compared to 2023. In 2021, sudden cardiac arrest accounted for 20,114 fatalities in U.S. Consequently, the growing prevalence of cardiovascular diseases fuels the cardiac marker testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp

What Long-Term Trends Will Define the Future of the Cardiac Marker Testing Market?
Key businesses in the cardiac marker testing market are prioritizing the creation of products that utilize advanced technology such as cardiac assays. These tests are intended to give accurate and crucial data about the state of the heart. By examining biomarkers and other indicators in blood or other samples, these assays can provide an evaluation of heart function, diagnose cardiovascular diseases, or approximate the risk of heart-related issues. For example, Mindray, a medical device firm based in China, introduced the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers in October 2023. The hs-cTnI assay is recognized for its superior sensitivity, accuracy, and reliability, achieving a detection rate of 93% between the limit of detection (LoD) and the 99th percentile upper reference limit (URL) and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL. This makes it exceedingly capable of identifying myocardial damage. In addition, Mindray's NT-proBNP assay, a significant indicator for heart failure, exhibits high precision with a coefficient of variation (CV) of =5%. It can also resist interference from 55 commonly used heart disease medications, ensuring precise detection and management of heart failure.

Which Segments in the Cardiac Marker Testing Market Offer the Most Profit Potential?
The cardiac marker testingmarket covered in this report is segmented -

1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:
1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
2) By Instruments: Point-of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19358&type=smp

Which Firms Dominate the Cardiac Marker Testing Market by Market Share and Revenue in 2025?
Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton dic*kinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

Which Regions Offer the Highest Growth Potential in the Cardiac Marker Testing Market?
North America was the largest region in the cardiac marker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19358

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.